JOURNAL OF PHARMACEUTICAL INNOVATION, vol.18, no.1, pp.325-338, 2023 (SCI-Expanded, Scopus)
Purpose The success of the treatment of lung diseases with minimized side effects depends on the optimum design of micro-particulate systems for pulmonary delivery that provide local delivery of drugs. This study aims to develop and evaluate optimized drug delivery systems against cystic fibrosis for pulmonary delivery.